GS-5745 as Monotherapy and in Combination With Chemotherapy in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Conditions:   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma
Interventions:   Drug: GS-5745;   Drug: S-1;   Drug: Cisplatin
Sponsor:   Gilead Sciences
Not yet recruiting - verified August 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/2b7WiiE
via IFTTT